Harvard Bioscience Inc

HBIO

Company Profile

  • Business description

    Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

  • Contact

    84 October Hill Road
    HollistonMA01746
    USA

    T: +1 508 893-8999

    E: [email protected]

    https://www.harvardbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    355

Stocks News & Analysis

stocks

The ultimate investing hack: dividend growth stocks

Finding companies built for lasting dividend growth.
stocks

Is the data centre party over for Goodman?

Global spending spree on data centres could mean a declining return on invested capital.
stocks

Is AUB an opportunity after shares plunge 17%?

After a takeover bid was withdrawn shares dropped to below the pre-bid price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,885.402.90-0.03%
CAC 408,074.6122.39-0.28%
DAX 4023,710.86121.420.51%
Dow JONES (US)47,474.46185.130.39%
FTSE 1009,701.800.73-0.01%
HKSE25,863.80231.25-0.89%
NASDAQ23,413.67137.750.59%
Nikkei 22550,102.66799.211.62%
NZX 50 Index13,582.5479.770.59%
S&P 5006,829.3716.740.25%
S&P/ASX 2008,585.305.00-0.06%
SSE Composite Index3,895.412.30-0.06%

Market Movers